Vinay Prasad’s Return to FDA Sends Biotech Shares Tumbling

The shares of biotech companies fell after news that ousted regulator Vinay Prasad is set to go back to the US Food and Drug Administration.

Prasad had previously overruled his own scientific review staff and took a confrontational approach that critics said would stymie scientific innovation and slow drug approvals.